MedTrace Logo

Anti-Inflammatory Diet in BRC Patients on Aromatase Inhibitors

NCT06214598 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2024-05-09

No results posted yet for this study

Summary

This project aims to decrease undesirable side effects and increase qulaity of life of aromatase inhibitors therapy in breast cancer survivors, by anti-inflammatory diet or supplementation.

Conditions

Interventions

DIETARY_SUPPLEMENT

Supplement

Supplements of anti-inflammatory oils rich in omega-3 and gamma-linolenic acid

DIETARY_SUPPLEMENT

AI diet

diet rich in whole grains, healthy oils and polyphenols,

DIETARY_SUPPLEMENT

Placebo

Placebo caps with standard diet

Sponsors & Collaborators

  • University of Belgrade

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-01
Primary Completion
2025-03-31
Completion
2026-11-30

Countries

  • Serbia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06214598 on ClinicalTrials.gov